Sensex Today | Stock Market LIVE Updates: Blue Star shares fall 8% from highs after negative commentary
Published on 06/11/2025 12:01 PM
The Nifty Midcap index is down over 450 points, as the index outperforms the benchmark indices.
The shares of Blue Star have fallen from the day’s high after the company’s negative commentary.
According to a survey released on Thursday (November 6), growth in India’s leading services sector dropped to a five-month low in October as unfavourable weather and competitive challenges tempered the robust pace observed in recent months.
Read Full Report
Total Subscription: 1.07x, QIBs: 0.10x, NIIs: 1.31x, Retail: 3.60x As Of 11:42 am On Day 2
On Thursday, November 6, shares of Epack Durables Ltd. dropped more than 10% in reaction to the company’s September quarter results, which showed that its losses for the quarter had increased from the previous year.
After reporting a loss of 6.1 crore for the same quarter last year, the company’s net loss for the quarter increased to ₹8.5 crore. This is true even though other revenue increased significantly from ₹70 lakh to ₹4.7 crore in the previous year.
Tata Exlsi | MoU With GSMA To Accelerate Operator Network Monetisation & Enterprise API Adoption
The Nifty Metal Index is under pressure, falling over 2% in the session so far.
These are some of the major volume buzzers among the Nifty 500 stocks with a volume trade higher than the 10-day average.
SpiceJet Has Inducted Five Additional Aircraft On Damp Lease Arrangement
Market at day’s low, metal and defence stocks under pressure
On Thursday, November 6, Redington Ltd.’s stock increased by more than 12% following the company’s announcement of robust year-over-year growth and a notable sequential improvement in performance. The margins stayed steady at about 2%.
SBI joins $100 billion market cap club as business crosses ₹100 lk cr mark
Piramal Pharma
HSBC/S&P Global October Services PMI At 58.9 Vs 60.9 In Sep
HSBC/S&P Global October Composite PMI At 60.4 Vs 61 In Sep
The shares of Ola Electric fell from their highs after the company reported its Q2 results.
Updater Services down over 13% on Q2 results impact
Orkla India Lists At ₹750.1/sh Vs Issue Price Of ₹730/sh On NSE
Zydus Life | Gets USFDA Orphan Drug Designation (ODD) For Desidustat For The Treatment Of betathalassemiaNewsLive TVMarketPopular CategoriesCalculatorsTrending NowLet's Connect with CNBCTV 18Network 18 Group :©TV18 Broadcast Limited. All rights reserved.